185 related articles for article (PubMed ID: 32073230)
1. Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non-severe haemophilia A.
Rejtő J; Königsbrügge O; Grilz E; Hofer S; Mauracher LM; Gabler C; Schuster G; Feistritzer C; Sunder-Plaßmann R; Quehenberger P; Gebhart J; Ay C; Pabinger I
J Thromb Haemost; 2020 May; 18(5):1081-1086. PubMed ID: 32073230
[TBL] [Abstract][Full Text] [Related]
2. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.
Albánez S; Ogiwara K; Michels A; Hopman W; Grabell J; James P; Lillicrap D
J Thromb Haemost; 2016 May; 14(5):953-63. PubMed ID: 26875505
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factor.
Elsheikh E; Lavin M; Heck LA; Larkin N; Mullaney B; Doherty D; Kennedy M; Keenan C; Guest T; O'Mahony B; Fazavana J; Fallon PG; Preston RJS; Gormley J; Ryan K; O'Connell NM; Singleton E; Byrne M; McGowan M; Roche S; Doyle M; Crowley MP; O'Shea SI; Reipert BM; Johnsen JM; Pipe SW; Di Paola J; Turecek PL; O'Donnell JS;
J Thromb Haemost; 2023 May; 21(5):1123-1134. PubMed ID: 36775768
[TBL] [Abstract][Full Text] [Related]
4. Factor VIII pharmacokinetics associates with genetic modifiers of VWF and FVIII clearance in an adult hemophilia A population.
Ogiwara K; Swystun LL; Paine AS; Kepa S; Choi SJ; Rejtö J; Hopman W; Pabinger I; Lillicrap D
J Thromb Haemost; 2021 Mar; 19(3):654-663. PubMed ID: 33219619
[TBL] [Abstract][Full Text] [Related]
5. Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors.
Biguzzi E; Castelli F; Lijfering WM; Cannegieter SC; Eikenboom J; Rosendaal FR; van Hylckama Vlieg A
Thromb Res; 2021 Jan; 197():172-178. PubMed ID: 33221577
[TBL] [Abstract][Full Text] [Related]
6. Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population.
Wang Z; Dou M; Du X; Ma L; Sun P; Cao H; Ye S; Jiang P; Liu F; Lin F; Zhang R; Li C
PeerJ; 2017; 5():e3156. PubMed ID: 28382235
[TBL] [Abstract][Full Text] [Related]
7. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
[TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.
Nossent AY; VAN Marion V; VAN Tilburg NH; Rosendaal FR; Bertina RM; VAN Mourik JA; Eikenboom HC
J Thromb Haemost; 2006 Dec; 4(12):2556-62. PubMed ID: 17059421
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels.
Hickson N; Hampshire D; Winship P; Goudemand J; Schneppenheim R; Budde U; Castaman G; Rodeghiero F; Federici AB; James P; Peake I; Eikenboom J; Goodeve A;
J Thromb Haemost; 2010 Sep; 8(9):1986-93. PubMed ID: 20492463
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
Boylan B; Rice AS; De Staercke C; Eyster ME; Yaish HM; Knoll CM; Bean CJ; Miller CH;
J Thromb Haemost; 2015 Jun; 13(6):1036-42. PubMed ID: 25780857
[TBL] [Abstract][Full Text] [Related]
11. Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women.
Ay C; Thom K; Abu-Hamdeh F; Horvath B; Quehenberger P; Male C; Mannhalter C; Pabinger I
Haemophilia; 2010 Jan; 16(1):111-7. PubMed ID: 19758307
[TBL] [Abstract][Full Text] [Related]
12. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
[TBL] [Abstract][Full Text] [Related]
13. Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients.
Swystun LL; Ogiwara K; Rawley O; Brown C; Georgescu I; Hopman W; Labarque V; Male C; Thom K; Blanchette VS; Carcao MD; Lillicrap D
Blood; 2019 Sep; 134(11):880-891. PubMed ID: 31350267
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Influence of ABO Blood Groups on Factor VIII and Its Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of 11,673 Subjects.
Song J; Chen F; Campos M; Bolgiano D; Houck K; Chambless LE; Wu KK; Folsom AR; Couper D; Boerwinkle E; Dong JF
PLoS One; 2015; 10(8):e0132626. PubMed ID: 26244499
[TBL] [Abstract][Full Text] [Related]
15. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
[TBL] [Abstract][Full Text] [Related]
16. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
[TBL] [Abstract][Full Text] [Related]
17. von Willebrand Factor and Factor VIII Clearance in Perioperative Hemophilia A Patients.
van Moort I; Bukkems LH; Heijdra JM; Schutgens REG; Laros-van Gorkom BAP; Nieuwenhuizen L; van der Meer FJM; Fijnvandraat K; Ypma P; de Maat MPM; Leebeek FWG; Meijer K; Eikenboom J; Mathôt RAA; Cnossen MH;
Thromb Haemost; 2020 Jul; 120(7):1056-1065. PubMed ID: 32480417
[TBL] [Abstract][Full Text] [Related]
18. Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease.
Biguzzi E; Siboni SM; le Cessie S; Baronciani L; Rosendaal FR; van Hylckama Vlieg A; Peyvandi F
J Thromb Haemost; 2021 Jan; 19(1):96-106. PubMed ID: 32998182
[TBL] [Abstract][Full Text] [Related]
19. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.
Rios DR; Fernandes AP; Figueiredo RC; Guimarães DA; Ferreira CN; Simões E Silva AC; Carvalho MG; Gomes KB; Dusse LM
J Thromb Thrombolysis; 2012 May; 33(4):416-21. PubMed ID: 22466813
[TBL] [Abstract][Full Text] [Related]
20. Influence of ABO blood group on von Willebrand factor tests in healthy Saudi blood donors.
Alharbi A; Hassan SB; Al-Momen AK; Al-Saleh K; Nasr R; Kohgear H; Owaidah T
Blood Coagul Fibrinolysis; 2018 Mar; 29(2):211-215. PubMed ID: 29369083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]